Literature DB >> 19495735

The Italian Horizon Scanning Project.

Roberta Joppi1, Luca Demattè, Anna Michela Menti, Daniela Pase, Chiara Poggiani, Luigi Mezzalira.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19495735     DOI： 10.1007/s00228-009-0666-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

Review 1.  Disappointing biotech.

Authors:  Roberta Joppi; Vittorio Bertele'; Silvio Garattini
Journal:  BMJ       Date:  2005-10-15

2.  Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003.

Authors:  Domenico Motola; Fabrizio De Ponti; Pasqualino Rossi; Nello Martini; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

3.  An update on the first decade of the European centralized procedure: how many innovative drugs?

Authors:  Domenico Motola; Fabrizio De Ponti; Elisabetta Poluzzi; Nello Martini; Pasqualino Rossi; Maria Chiara Silvani; Alberto Vaccheri; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

4.  Drug eluting stents.

Authors:  A H Gershlick; G Richardson
Journal:  BMJ       Date:  2006-12-16

Review 5.  Priority setting for health technology assessments: a systematic review of current practical approaches.

Authors:  Hussein Z Noorani; Donald R Husereau; Rhonda Boudreau; Becky Skidmore
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

6.  Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systems.

Authors:  Kieran Murphy; Claire Packer; Andrew Stevens; Sue Simpson
Journal:  Int J Technol Assess Health Care       Date:  2007       Impact factor: 2.188

Review 7.  How can we regulate medicines better?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  BMJ       Date:  2007-10-20

8.  Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.

Authors:  Stephen D Wiviott; Eugene Braunwald; Dominick J Angiolillo; Simha Meisel; Anthony J Dalby; Freek W A Verheugt; Shaun G Goodman; Ramon Corbalan; Drew A Purdy; Sabina A Murphy; Carolyn H McCabe; Elliott M Antman
Journal:  Circulation       Date:  2008-08-31       Impact factor: 29.690

Review 9.  Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.

Authors:  Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2009-02-02       Impact factor: 2.778

10.  Haematological anticancer drugs in Europe: any added value at the time of approval?

Authors:  Vittorio Bertele'; Rita Banzi; Filippo Capasso; Giovanni Tafuri; Francesco Trotta; Giovanni Apolone; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2007-05-25       Impact factor: 3.064
View more
  8 in total

Review 1.  Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Authors:  Jakub Adamski; Brian Godman; Gabriella Ofierska-Sujkowska; Bogusława Osińska; Harald Herholz; Kamila Wendykowska; Ott Laius; Saira Jan; Catherine Sermet; Corrine Zara; Marija Kalaba; Roland Gustafsson; Kristina Garuolienè; Alan Haycox; Silvio Garattini; Lars L Gustafsson
Journal:  BMC Health Serv Res       Date:  2010-06-07       Impact factor: 2.655

2.  The role of health technology assessment bodies in shaping drug development.

Authors:  Oriana Ciani; Claudio Jommi
Journal:  Drug Des Devel Ther       Date:  2014-11-10       Impact factor: 4.162

3.  Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Authors:  Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Fürst; Kristina Garuolienė; Martin van der Graaff; Jolanta Gulbinovič; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic-Pekovic; Laura McCullagh; Einar Magnusson; Ellen Nilsen; Gisbert Selke; Catherine Sermet; Steven Simoens; Robert Sauermann; Ad Schuurman; Ricardo Ramos; Vera Vlahovic-Palcevski; Corinne Zara; Brian Godman
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

4.  Scanning the horizon: a systematic literature review of methodologies.

Authors:  Philip Hines; Li Hiu Yu; Richard H Guy; Angela Brand; Marisa Papaluca-Amati
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

Review 5.  "Ready for the future?" - Status of national and cross-country horizon scanning systems for medicines in European countries.

Authors:  Sabine Vogler
Journal:  Ger Med Sci       Date:  2022-03-31

Review 6.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775

Review 7.  The Early Awareness and Alert System in Sweden: History and Current Status.

Authors:  Irene Eriksson; Björn Wettermark; Marie Persson; Morgan Edström; Brian Godman; Anna Lindhé; Rickard E Malmström; Helena Ramström; Mia von Euler; Anna Bergkvist Christensen
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

Review 8.  A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development.

Authors:  Zahra Goudarzi; Shekoufeh Nikfar; Abbas Kebriaeezadeh; Reza Yousefi Zenouz; Akbar Abdollahi Asl; Nader Tavakoli
Journal:  Med J Islam Repub Iran       Date:  2021-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.